Literature DB >> 23273289

There must be a better way: piloting alternate routes around heart failure hospitalizations.

Akshay S Desai1, Lynne W Stevenson.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23273289     DOI： 10.1016/j.jacc.2012.10.015

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  4 in total

1.  HerzMobil Tirol network: rationale for and design of a collaborative heart failure disease management program in Austria.

Authors:  Andreas Von der Heidt; Elske Ammenwerth; Karl Bauer; Bettina Fetz; Thomas Fluckinger; Andrea Gassner; Willhelm Grander; Walter Gritsch; Immaculata Haffner; Gudrun Henle-Talirz; Stefan Hoschek; Stephan Huter; Peter Kastner; Susanne Krestan; Peter Kufner; Robert Modre-Osprian; Josef Noebl; Momen Radi; Clemens Raffeiner; Stefan Welte; Andreas Wiseman; Gerhard Poelzl
Journal:  Wien Klin Wochenschr       Date:  2014-11-13       Impact factor: 1.704

Review 2.  Systolic heart failure: knowledge gaps, misconceptions, and future directions.

Authors:  Rohan Samson; Rohit Ramachandran; Thierry H Le Jemtel
Journal:  Ochsner J       Date:  2014

3.  Early use of remote dielectric sensing after hospitalization to reduce heart failure readmissions.

Authors:  Anuradha Lala; Maya H Barghash; Gennaro Giustino; Jesus Alvarez-Garcia; Swiri Konje; Aditya Parikh; Jennifer Ullman; Brendan Keith; John Donehey; Sumeet S Mitter; Maria Giovanna Trivieri; Johanna P Contreras; Daniel Burkhoff; Noah Moss; Donna M Mancini; Sean P Pinney
Journal:  ESC Heart Fail       Date:  2020-12-18

4.  Risk for non-home discharge following surgery for ischemic mitral valve disease.

Authors:  Anuradha Lala; Helena L Chang; Xiaoyu Liu; Eric J Charles; Babatunde A Yerokun; Michael E Bowdish; Vinod H Thourani; Michael J Mack; Marissa A Miller; Patrick T O'Gara; Eugene H Blackstone; Alan J Moskowitz; Annetine C Gelijns; John C Mullen; Lynne W Stevenson
Journal:  J Thorac Cardiovasc Surg       Date:  2020-03-04       Impact factor: 5.209
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.